Table 1.
Possible targets of microRNA-124 in ischemic encephalopathy.
Diseases | Targets | Abbreviations | Function | Effects | Refs |
---|---|---|---|---|---|
Ischemic stroke | SRY-box transcription factor | Sox9 | Neuronal differentiation | Repressing the expression of Sox9 | [24] |
Jagged-1 | JAG1 | Neuronal differentiation | Repressing JAG1/Notch signaling pathway | [33] | |
Ubiquitin specific peptidase 14 | Usp14 | Neuronal differentiation Neurovascular remodeling |
Decreasing the expression of Usp14, which mediates REST degradation | [37] | |
Anti-apoptosis | Exosomal miR-124 derived from M2 microglia attenuates neuronal apoptosis via downregulating Usp14 | [38] | |||
Phosphoinositide 3-kinase | PI3K | Anti-axonal growth | Inhibition of miR-124 activating PI3K/AKT/mTOR/GAP-43 pathway | [39] | |
Anti-apoptosis | Activating PI3K/AKT/ Bcl-2 signaling pathway | [40] | |||
Activating PI3K/AKT/Nrf2 signaling pathway | [41] | ||||
Anti-oxidative stress | Activating PI3K/AKT/Nrf2 signaling pathway | [41] | |||
Inhibitory member of the apoptosis-stimulating proteins of p53 family | iASPP | Pro-apoptosis | Downregulating the expression of iASPP | [36] | |
B-cell lymphoma-2 B-cell lymphoma-extra large |
Bcl-2/Bcl-xl | Anti-apoptosis | Upregulating the expression of Bcl-2 and Bcl-xl respectively | [42] | |
Janus kinase 2 | JAK2 | Anti-apoptosis | Activating JAK2/STAT3/Bcl-2 signaling pathway | [16] | |
X-ray repair cross-complementing protein 6 | Ku70 | Pro-apoptosis | Knockdown of miR-124 attenuates I/R-induced apoptosis via negatively regulating Ku 70 | [43] | |
CCAAT/enhancer-binding protein alpha | C/EBP-α | Anti-inflammation | Inhibiting C/EBP-α/PU.1 signaling pathway | [22] | |
RE1-silencing transcription factor | REST | Neuroplasticity Angiogenesis |
Facilitating REST degradation | [44] | |
Alzheimer’s disease | Regulatory factor X1 | RFX1 | Anti-Aβ deposition | Decreased miR-124 represses ApoE-dependent Aβ uptake by targeting and upregulating RFX1 | [34] |
cAMP-response element binding protein | CREB | Suppressing synaptic plasticity | Decreased miR-124 increases the expression of CREB and subsequent BDNF synthesis | [45] | |
Tyrosine-protein phosphatase non-receptor type 1 | PTPN1 | Suppressing synaptic plasticity | Downregulating the expression of PTPN1 | [46] | |
Beta-site Amyloid precursor protein Cleaving Enzyme 1 | BACE1 | Anti- Aβ deposition | Decreased miR-124 upregulates BACE1 level | [47] | |
Caveolin-1 | Cav-1 | Inhibiting hyperphosphorylation of tau | Repressing the expression of Cav-1, which further activates PI3K/AKT/GSK3β signaling pathway | [35] | |
Parkinson’s disease | Bim | Bim | Anti-apoptosis Anti-autophagy |
Inhibiting the expression of Bim and reducing Bax translocation to mitochondria and lysosomal membrane | [23] |
Adenosine 5’-monophosphate-activated protein kinase | AMPK | Anti-apoptosis Anti-autophagy |
Decreased miR-124 induces apoptosis and autophagy-associated proteins via activating AMPK/mTOR signaling pathway | [48] | |
Signal transducer and activator of transcription-3 | STAT3 | Anti-apoptosis | Suppressing STAT3 expression | [49] | |
AnnexinA5 | ANXA5 | Anti-apoptosis | Downregulating ANXA5/ERK signaling pathway | [50] | |
Caspase-3 | Casp-3 | Anti-apoptosis | Restraining the increase of Casp-3 | [51] | |
Mitogen-activated protein kinase kinase kinase 3 | MEKK3 | Anti-neuroinflammation | Suppressing MEKK3/NF-κB signaling pathway | [52] | |
Sequestosome 1 Phospho-p38 mitogen-activated protein kinase |
p62 p-p38 |
Anti-inflammation | Suppressing the expression of p62 and p-p38 | [53] | |
Calpain 1 | Calpain 1 | Anti-oxidative stress | Decreased miR-124 upregulates the expression of calpain1/p25/CDK5 pathway proteins | [17] | |
Epilepsy | cAMP-response element-binding protein 1 | CREB1 | Anti-neuronal excitability | Repressing the expression of CREB1 | [32] |
CCAAT/enhancer-binding protein alpha | C/EBPα | Anti-epileptogenic | Downregulating C/EBPα level, which then inhibits the expression and activity of NRSF | [54] | |
Bcl-2-like 13 | Bcl2L13 | Anti-apoptosis | Diminishing the expression of Bcl2L13, which further represses the activation of caspase-3 | [55] |